The harsh reality of AI is that it will eliminate jobs, but Andy submits that the experts are the ones who need to run AI, ...

Using a reconfigured common-mode choke as an isolation transformer to analyze the open-loop response of a Peltz oscillator.

This paper presents a literature review on magnetically-controlled devices, variable inductors (VI), and variable transformers (VT), and their applications to lighting gears for discharge lamps and/or ...

How in-house patent pros are ‘enablers of innovation’ Iti Negi, a senior patent engineer at Mercedes-Benz, outlines how in-house teams can drive a more effective, inventor-friendly patent process.

BLM15VM is an automotive ferrite beads inductor intended to block frequencies around 5.9GHz. Announced by Murata, it is particularly intended for 5G vehicle-to-everything (5G-V2X) applications. “In ...

TDK Corp. has launched the ADL8030VA, a high-performance inductor designed specifically for power-over-coaxial (PoC) applications. Due to its high impedance over a wide frequency range, this component ...

IngenioShare sued Epic in Texas in 2021 over several of the same patents, in a suit that was dismissed in 2022 for improper venue. In the current suit, now filed in federal court in North Carolina, ...

“Petitioner’s awareness of Patent Owner’s applications and failure to seek early review of the patents favors denial and outweighs the above-discussed considerations.”- Director’s ...

The University of Nebraska (NU) system landed among the top 100 universities with the most U.S. utility patents granted in the 2024 calendar year. NU’s 47 patents ranked No. 49 in the U.S. and No. 82 ...

The patent application, if approved, will strengthen Bone Biologics’ intellectual property portfolio and support the Company’s strategic plan to advance the clinical development program.

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is among the 13 Biotech Stocks with Huge Upside Potential. It declared that the U.S. Court of Appeals maintained the legality of its composition of matter ...

“We are pleased to strengthen our intellectual property for istaroxime with this patent for the United States,” said Jed Latkin, CEO of Windtree. “Istaroxime is approaching Phase 3 readiness ...